1
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure Due to Acetaminophen
Condition(s): Acute Liver Failure; Acute Liver Injury Last Updated: February 8, 2013Recruiting
10 Clinical Trials for: “Phenylacetic Acid”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition(s): Hepatic Encephalopathy Last Updated: April 27, 2011Withdrawn
3
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
Condition(s): Gastrointestinal Bleeding; Cirrhosis Last Updated: June 20, 2012Recruiting
4
Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
Condition(s): Brain and Central Nervous System Tumors Last Updated: July 23, 2008Completed
5
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Condition(s): Amino Acid Metabolism, Inborn Errors Last Updated: June 23, 2005Completed
6
Emergency Use of OCR-002 in Acute Liver Failure
Condition(s): Acute Liver Failure Last Updated: July 2, 2012Enrolling by invitation
7
A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)
Condition(s): Healthy Last Updated: September 15, 2009Completed
8
Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors
Condition(s): Brain Tumor Last Updated: March 3, 2008Completed
9
Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy
Condition(s): Brain Neoplasms; Neuroblastoma Last Updated: March 3, 2008Completed
10
A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group
Condition(s): Hepatic Encephalopathy; Urea Cycle Disorders Last Updated: September 28, 2009Completed
